107 related articles for article (PubMed ID: 35401674)
1.
Jain AS; Sushma P; Dharmashekar C; Beelagi MS; Prasad SK; Shivamallu C; Prasad A; Syed A; Marraiki N; Prasad KS
Saudi J Biol Sci; 2021 Jan; 28(1):1040-1051. PubMed ID: 33424398
[TBL] [Abstract][Full Text] [Related]
2. A Repurposed Drug Screen Identifies Compounds That Inhibit the Binding of the COVID-19 Spike Protein to ACE2.
Tsegay KB; Adeyemi CM; Gniffke EP; Sather DN; Walker JK; Smith SEP
Front Pharmacol; 2021; 12():685308. PubMed ID: 34194331
[TBL] [Abstract][Full Text] [Related]
3. A novel inhibitor of SARS-CoV infection: Lactulose octasulfate interferes with ACE2-Spike protein binding.
Pashameah RA; Soltane R; Sayed AM
Heliyon; 2024 Jan; 10(1):e23222. PubMed ID: 38163229
[TBL] [Abstract][Full Text] [Related]
4. Safety, efficacy, and pharmacokinetics of nirmatrelvir and ritonavir in patients with severe COVID-19 and renal impairment: A case report.
Zheng R; Fan X; Zhou F; Ye X; Sun J; Cheng J; Yuan Y; Wang Y; Cai X; Wei A
Heliyon; 2024 Mar; 10(6):e28069. PubMed ID: 38515712
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 Syncytium under the Radar: Molecular Insights of the Spike-Induced Syncytia and Potential Strategies to Limit SARS-CoV-2 Replication.
Ali H; Naseem A; Siddiqui ZI
J Clin Med; 2023 Sep; 12(18):. PubMed ID: 37763019
[TBL] [Abstract][Full Text] [Related]
6. Cyclic lipopeptides as membrane fusion inhibitors against SARS-CoV-2: New tricks for old dogs.
Shekunov EV; Zlodeeva PD; Efimova SS; Muryleva AA; Zarubaev VV; Slita AV; Ostroumova OS
Antiviral Res; 2023 Apr; 212():105575. PubMed ID: 36868316
[TBL] [Abstract][Full Text] [Related]
7. Antiviral Activity of Micafungin and Its Derivatives against SARS-CoV-2 RNA Replication.
Nakajima S; Ohashi H; Akazawa D; Torii S; Suzuki R; Fukuhara T; Watashi K
Viruses; 2023 Feb; 15(2):. PubMed ID: 36851666
[TBL] [Abstract][Full Text] [Related]
8. Fusion assays for screening of fusion inhibitors targeting SARS-CoV-2 entry and syncytia formation.
Chan SW
Front Pharmacol; 2022; 13():1007527. PubMed ID: 36438831
[TBL] [Abstract][Full Text] [Related]
9. Antiviral activity and mechanism of the antifungal drug, anidulafungin, suggesting its potential to promote treatment of viral diseases.
Shen S; Zhang Y; Yin Z; Zhu Q; Zhang J; Wang T; Fang Y; Wu X; Bai Y; Dai S; Liu X; Jin J; Tang S; Liu J; Wang M; Guo Y; Deng F
BMC Med; 2022 Oct; 20(1):359. PubMed ID: 36266654
[TBL] [Abstract][Full Text] [Related]
10. Isolation and In Silico Inhibitory Potential against SARS-CoV-2 RNA Polymerase of the Rare Kaempferol 3-
Suleimen YM; Jose RA; Mamytbekova GK; Suleimen RN; Ishmuratova MY; Dehaen W; Alsfouk BA; Elkaeed EB; Eissa IH; Metwaly AM
Plants (Basel); 2022 Aug; 11(15):. PubMed ID: 35956550
[TBL] [Abstract][Full Text] [Related]
11. Molecular insights into the structural and dynamical changes of calcium channel TRPV6 induced by its interaction with phosphatidylinositol 4,5-bisphosphate.
Wang L; Cai R; Chen XZ; Peng JB
J Biomol Struct Dyn; 2023; 41(14):6559-6568. PubMed ID: 35950523
[TBL] [Abstract][Full Text] [Related]
12. Targeting non-structural proteins of Hepatitis C virus for predicting repurposed drugs using QSAR and machine learning approaches.
Kamboj S; Rajput A; Rastogi A; Thakur A; Kumar M
Comput Struct Biotechnol J; 2022; 20():3422-3438. PubMed ID: 35832613
[TBL] [Abstract][Full Text] [Related]
13. Anti-Fungal Drug Anidulafungin Inhibits SARS-CoV-2 Spike-Induced Syncytia Formation by Targeting ACE2-Spike Protein Interaction.
Ahamad S; Ali H; Secco I; Giacca M; Gupta D
Front Genet; 2022; 13():866474. PubMed ID: 35401674
[TBL] [Abstract][Full Text] [Related]
14. Screening of inhibitors against SARS-CoV-2 spike protein and their capability to block the viral entry mechanism: A viroinformatics study.
Farouk AE; Baig MH; Khan MI; Park T; Alotaibi SS; Dong JJ
Saudi J Biol Sci; 2021 Jun; 28(6):3262-3269. PubMed ID: 33654454
[TBL] [Abstract][Full Text] [Related]
15. Screening of Natural Products Targeting SARS-CoV-2-ACE2 Receptor Interface - A MixMD Based HTVS Pipeline.
Gopinath K; Jokinen EM; Kurkinen ST; Pentikäinen OT
Front Chem; 2020; 8():589769. PubMed ID: 33330376
[TBL] [Abstract][Full Text] [Related]
16. Testing of the inhibitory effects of loratadine and desloratadine on SARS-CoV-2 spike pseudotyped virus viropexis.
Hou Y; Ge S; Li X; Wang C; He H; He L
Chem Biol Interact; 2021 Apr; 338():109420. PubMed ID: 33609497
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
